Kerrisdale Advisers’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-68,778
Closed -$2.03M 119
2025
Q4
$2.03M Hold
68,778
0.95% 28
2025
Q3
$1.74M Hold
68,778
0.9% 32
2025
Q2
$1.65M Sell
68,778
-59,450
-46% -$1.38M 0.86% 27
2025
Q1
$2.94M Buy
128,228
+15,333
+14% +$370K 1.23% 19
2024
Q4
$2.86M Buy
112,895
+38,545
+52% +$977K 0.97% 26
2024
Q3
$1.85M Buy
+74,350
New +$2.2M 0.63% 42

Other funds holding RTO

Kerrisdale Advisers's RTO Position: Q1 2026 in Review

Kerrisdale Advisers sold out of Rentokil (RTO) in Q1 2026, closing a stake of 68,778 shares — an estimated $2.03M sold.

Kerrisdale Advisers first reported a position in RTO in Q3 2024 and held it in 6 quarters. The position peaked at $2.94M in Q1 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Kerrisdale Advisers reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
  • Kerrisdale Advisers sold 68,778 Rentokil shares in Q1 2026, an estimated $2.03M.
  • Kerrisdale Advisers first reported a position in Rentokil in Q3 2024 and held it in 6 quarters.
  • Kerrisdale Advisers's Rentokil position peaked at $2.94M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Kerrisdale Advisers's 13F filing for Q1 2026, filed 15 May 2026.